Pharmaceuticals, Biotechnology and Life Sciences
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration,…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration,…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration,…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Packaging Market – Forecasts from 2020 to 2025” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Packaging Market – Forecasts from 2020 to 2025” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Packaging Market – Forecasts from 2020 to 2025” report has been added to ResearchAndMarkets.com’s offering. The…
– Primary endpoint achieved in global, randomized, Phase 3 study of omidubicel; Initiation of BLA submission planned for fourth quarter…
– Primary endpoint achieved in global, randomized, Phase 3 study of omidubicel; Initiation of BLA submission planned for fourth quarter…
– Primary endpoint achieved in global, randomized, Phase 3 study of omidubicel; Initiation of BLA submission planned for fourth quarter…